The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s female fertility and pregnancy rapid test market report forecasts the female fertility and pregnancy rapid test market size to grow to $1.67 Billion by 2027, with a CAGR (compound annual growth rate) of more than 5%.

Learn More On The Female Fertility And Pregnancy Rapid Test Market Report 2023 – https://www.thebusinessresearchcompany.com/report/female-fertility-and-pregnancy-rapid-test-global-market-report

Female Fertility And Pregnancy Rapid Test Market Size Forecast
The global female fertility and pregnancy rapid test market is expected to grow from $1.26 billion in 2022 to $1.34 billion in 2023 at a compound annual growth rate (CAGR) of 6.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global female fertility and pregnancy rapid test market size is expected to grow to $1.67 billion in 2027 at a CAGR of 5.6%.

North America held the largest female fertility and pregnancy rapid test market share.

Key Female Fertility And Pregnancy Rapid Test Market Driver ­– Increase In The Incidence Of Gynecological Disorders
According to a February 2022 article published by the World Health Organization, a Switzerland-based global health agency, cervical cancer is the fourth most common cancer in women worldwide, with 604,000 new cases and 342,000 deaths expected in 2020. In 2020, low- and middle-income countries accounted for more than 90% of new cases and deaths globally. As a result, the rising prevalence of gynaecological disorders is propelling the female fertility and pregnancy rapid test market forward.

Request for A Sample Of The Global Female Fertility And Pregnancy Rapid Test Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8966&type=smp

Key Female Fertility And Pregnancy Rapid Test Market Trend – Product Innovations
To maintain their market position, major corporations are developing innovative test kits. For example, Salignostics, an Israel-based research and development firm specialising in the development of saliva-based rapid diagnostic assays, launched Sailstick, a saliva-based pregnancy test, in November 2022. Salistick is the first rapid saliva-based pregnancy test with an improved user interface and high sensitivity for early pregnancy detection. The kit is based on the company’s revolutionary technology for detecting the pregnancy hormone -HCG in saliva. People who take the test place one component of the test kit in their mouth for several seconds to collect saliva before placing it in a testing tube, which produces results in less than 10 minutes.

Female Fertility And Pregnancy Rapid Test Market Segment
1) By Product: Fertility Rapid Test Kits, Pregnancy Rapid Test Kits
2)By Device Type: Digital Devices, Line-indicator Devices
3)By Test Type: FSH Urine Test, LH Urine Test, hCG Blood Test, hCG Urine Test
4)By Distribution Channel: Hospital Channel, Retail Channel, Online Channel

Female Fertility And Pregnancy Rapid Test Market Major Players and Strategies
Major players in the female fertility and pregnancy rapid test market are Abbott Laboratories, Atlas Medical GmbH, bioMérieux SA, Church & Dwight Co. Inc., Quidel Corporation, Egens Group, Eurofins Scientific, Everlywell Inc., Genea Pty Limited, Geratherm Medical AG, Mankind Pharma, SA Scientific Ltd., Artron Laboratories Inc., PRIMA Lab SA, and Procter & Gamble.

Modern Fertility was acquired by Ro, a US-based telehealth company, for an undisclosed sum in May 2021. Modern Fertility is expected to be integrated with Ro’s nationwide platform and infrastructure as part of the acquisition in order to expand its operations and existing capabilities while also developing new personalised healthcare experiences. Modern Fertility is a company based in the United States that creates home diagnostic kits for women.

The Female Fertility And Pregnancy Rapid Test Global Market Report 2023 covers regional data on female fertility and pregnancy rapid test market size, female fertility and pregnancy rapid test market trends and drivers, opportunities, strategies, and female fertility and pregnancy rapid test market competitor analysis. The countries covered in the female fertility and pregnancy rapid test market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Female fertility and pregnancy rapid tests are a method of testing fertility and pregnancy in women at the doctor’s office using drugstore urine tests and blood tests. Rapid fertility and pregnancy test kits are a simple, user-friendly fertility testing solution used to detect ovulation and/or diagnose infertility in females.

View More Reports Related To The Female Fertility And Pregnancy Rapid Test Market –
Fertility Drugs Global Market Report 2023
Fertility Treatments Global Market Report 2023
Fertility Services Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: